BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$323M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$345M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$305M |
| 4 |
PPLI
People Inc
PPLI
|
+$203M |
| 5 |
Visa
V
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.89% |
| 2 | Consumer Discretionary | 7.29% |
| 3 | Healthcare | 5.23% |
| 4 | Financials | 5.21% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPYU
3751
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $15.9K | ﹤0.01% |
1,298
-3,045
| -70% | -$34.9K |
|
|
MFGP
3752
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $15.8K | ﹤0.01% |
4,897
| – | – |
|
3753
First Western Financial
MYFW
$308M
| $15.7K | ﹤0.01% |
1,212
+978
| +418% | +$13.4K |
|
|
MBII
3754
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $15.7K | ﹤0.01% |
12,845
+9,590
| +295% | +$11.7K |
|
3755
Mastech Digital
MHH
$92.5M
| $15.7K | ﹤0.01% |
870
+724
| +496% | +$15.1K |
|
3756
Evolution Petroleum
EPM
$135M
| $15.7K | ﹤0.01% |
6,989
+5,817
| +496% | +$15.5K |
|
3757
ProShares Ultra 7-10 Year Treasury
UST
$13.8M
| $15.6K | ﹤0.01% |
206
-372
| -64% | -$28.3K |
|
|
NH
3758
DELISTED
NantHealth, Inc
NH
| $15.6K | ﹤0.01% |
446
+378
| +556% | +$21.3K |
|
3759
OP Bancorp
OPBK
$236M
| $15.6K | ﹤0.01% |
2,733
+2,326
| +571% | +$14.6K |
|
3760
NextDecade
NEXT
$1.83B
| $15.2K | ﹤0.01% |
5,104
+2,760
| +118% | +$5.5K |
|
|
GFN
3761
DELISTED
General Finance Corporation
GFN
| $15.2K | ﹤0.01% |
2,394
+2,070
| +639% | +$13.2K |
|
3762
Landmark Bancorp
LARK
$197M
| $15K | ﹤0.01% |
942
+753
| +398% | +$12.1K |
|
3763
ARK Genomic Revolution ETF
ARKG
$1.79B
| $15K | ﹤0.01% |
+235
| New | +$13.8K |
|
|
TYME
3764
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $14.8K | ﹤0.01% |
15,139
+10,905
| +258% | +$12.6K |
|
|
AXLA
3765
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $14.8K | ﹤0.01% |
128
+116
| +967% | +$14.3K |
|
|
ATXI
3766
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $14.8K | ﹤0.01% |
+1
| New | +$12.2K |
|
3767
Arq
ARQ
$102M
| $14.8K | ﹤0.01% |
3,643
+2,808
| +336% | +$12K |
|
3768
Greene County Bancorp
GCBC
$599M
| $14.7K | ﹤0.01% |
1,358
+1,080
| +388% | +$12K |
|
|
PAMT
3769
PAMT Corp
PAMT
$285M
| $14.7K | ﹤0.01% |
1,564
+1,296
| +484% | +$11.1K |
|
3770
Rimini Street
RMNI
$445M
| $14.6K | ﹤0.01% |
4,528
+2,954
| +188% | +$13.6K |
|
3771
Abeona Therapeutics
ABEO
$373M
| $14.6K | ﹤0.01% |
571
+478
| +514% | +$30.1K |
|
3772
Cibus
CBUS
$147M
| $14.5K | ﹤0.01% |
53
+32
| +152% | +$8.68K |
|
3773
Ponce Financial Group
PDLB
$501M
| $14.5K | ﹤0.01% |
2,291
+1,807
| +373% | +$11.8K |
|
3774
PAVmed
PAVM
$31.8M
| $14.4K | ﹤0.01% |
18
+15
| +500% | +$13.3K |
|
3775
Ericsson
ERIC
$33.8B
| $14.3K | ﹤0.01% |
1,315
-32,989
| -96% | -$364K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2020 Portfolio in Review
As of Q3 2020, BNP Paribas Financial Markets held 4,385 positions worth $69.9B, up 23% from $56.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $2.99B of net new capital in Q3 2020, opening 85 new positions and adding to 2,667 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $345M trimmed.
- BNP Paribas Financial Markets's largest Q3 2020 buy was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q3 2020, an estimated $1.93B increase.
- BNP Paribas Financial Markets's biggest Q3 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $345M.
- BNP Paribas Financial Markets fully exited People Inc in Q3 2020, selling an estimated $203M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $69.9B portfolio in Q3 2020.
- BNP Paribas Financial Markets opened 85 new positions and closed 175 in Q3 2020.
- BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $69.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.